<table class="naaccr-summary-table naaccr-borders">
  <tr>
    <th class="naaccr-summary-header naaccr-borders">Item #</th>
    <th class="naaccr-summary-header naaccr-borders">Length</th>
    <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
    <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
    <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
  </tr>
  <tr>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">764</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">SEER</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">16</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
  </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.summaryStage2018<br/><br/>
<strong>Alternate Names</strong>
<br/>&nbsp;&nbsp;&nbsp;Directly Assigned SS2018

<div class='content chap10-para-head'><strong>Description</strong></div>
<div class='content chap10-para'>
<p>This item stores the directly assigned Summary Stage 2018. Effective for cases diagnosed 1/1/2018+.</p>

</div>

<div class='content chap10-para-head'><strong>Rationale</strong></div>
<div class='content chap10-para'>
<p>The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups cases into broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.</p>

</div>


<div class='content chap10-para'>
<p><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</p>

</div>

<div class='content chap10-para'><p><strong>Codes</strong></p>
</div>
<table>
        <tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>In situ</td></tr>
        <tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>Localized only</td></tr>
        <tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>Regional by direct extension only</td></tr>
        <tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Regional lymph nodes only</td></tr>
        <tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Regional by BOTH direct extension AND lymph node involvement</td></tr>
        <tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Distant site(s)/node(s) involved</td></tr>
        <tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Benign/borderline\*</td></tr>
        <tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Unknown if extension or metastasis (unstaged, unknown, or unspecified)  
 Death certificate only case</td></tr>
</table>

<div class='content chap10-para'>
<p>*Applicable for the following SS2018 chapters: Brain, CNS Other, Intracranial Gland.</p>
<p><em>Note</em>: For SS2018, code 5 for “Regional, NOS” can no longer be coded. Code 5 (Regional, NOS) is still applicable.</p>

</div>
